Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer

Fiche du document

Auteur
Date

21 février 2024

Discipline
Types de document
Périmètre
Identifiant
Source

ELSIBI

Collection

Hypothèses : carnets de recherches en Sciences humaines et sociales

Organisation

OpenEdition

Licence

info:eu-repo/semantics/openAccess

Sujets proches En

Trade

Citer ce document

adelage, « Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer », ELSIBI, ID : 10.58079/vvnf

Métriques

Partage / Export

Résumé 0

London, UK, 1 August 2023: The Cell and Gene Therapy Catapult (CGT Catapult) today announces that Jeanette Evans has been appointed Chief Business Officer (CBO), taking over from Sharon Brownlow, with effect in August 2023. Jeanette is a senior business development executive with over 25 years' experience in the pharmaceutical industry including working for leading companies such as AstraZeneca and Merck. Published on the 1st of August 2023. Read the full news report here, Cell and Gene Ther...

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Sur les mêmes disciplines

Exporter en